A novel assay to assess the effect of pharmaceutical compounds on the differentiation of podocytes.

Frances KindtElke HammerStefan KemnitzAntje BlumenthalPaul KlemmRabea SchlüterSusan E QuagginJens van den BrandtGeorg FuellenUwe VölkerKarlhans EndlichNicole Endlich

Published in: British journal of pharmacology (2016)

In summary, we established a novel assay to assess the effect of pharmaceutical compounds on the differentiation of podocytes in situ. Our assay is suitable for compound screening to identify drugs for the treatment of glomerulopathies.

Keyphrases

high throughput
diabetic nephropathy
smoking cessation